Columbia Care Raises $35 Million with Sale/Leaseback Transactions in Three States

Columbia Care Announces Execution of Definitive Agreement for Sale-Leaseback with NewLake Capital Increasing Liquidity By $35 Million
  • First sale-leaseback initiated by Columbia Care will close before year end 2019 and includes six of 15 properties
  • Inaugural program sets precedent for subsequent sale-leasebacks involving additional properties expected to be announced over the next several quarters
  • With $85 million of cash on balance sheet at end of 3Q 2019 and no debt, non-dilutive financings will materially enhance liquidity in advance of Columbia Care turning adjusted EBITDA positive in 2020

NEW YORK, December 12, 2019–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest fully integrated operators in the global medical cannabis industry with licenses across the US and EU, today announced the signing of a definitive binding agreement for its first sale-leaseback with NewLake Capital (“NewLake”) valued at $35 million. The transaction involves six properties totaling 127,000 square feet in California, Illinois and Massachusetts. This first agreement will close by the end of 2019 with subsequent programs to be announced in 2020 as Columbia Care continues to evaluate similar non-dilutive financing opportunities to maintain strategic and financial flexibility.

Real estate assets sold under the terms of the agreement include a dispensary in San Diego, California, a dispensary in Chicago, Illinois, dispensaries in Greenfield and Lowell, Massachusetts, as well as cultivation and manufacturing facilities in Lowell, Massachusetts and Aurora, Illinois. The incremental $35 million in liquidity, together with Columbia Care’s existing cash position, will allow the Company to accelerate its pathway to profitability in 2020 by continuing to optimize its operations to drive revenue, target cost savings and improve efficiencies and margins across all licensed markets. In addition, this capital will allow Columbia Care to solidify its long-term market share advantage by facilitating product innovation and enabling the expansion of its differentiated services, as well as opportunistically take advantage of market-driven dislocations through targeted M&A and consolidation of distressed assets.

With no debt and a substantial cash position, Columbia Care possesses one of the strongest balance sheets in the industry. Reflecting the high quality of our assets, locations and operations, this attractively priced financing option affirms the premium reputation institutional investors ascribe to Columbia Care.

Nicholas Vita, chief executive officer of Columbia Care

As our markets come on-line and mature, we intend to demonstrate the power and scale of our economic model by generating positive cashflow at the individual product, facility and market levels, as well as on a consolidated basis.

“Following the completion of our 2019 capital expenditure and market development plan, with a diverse suite of financing options at our disposal, strong balance sheet and disciplined execution strategy, we look forward to continuing our triple-digit annual growth rates into 2020 and beyond. Columbia Care plans on emerging from the current market environment as the global industry leader with a consolidated, scaled platform capable of driving best-in-class profitability.”

We are excited to partner with one of the leading cannabis companies in the US and are proud to support Columbia Care’s mission to improve lives by providing innovative, high-quality health and wellness products tailored to meet the evolving needs of its consumers.

Anthony Coniglio, chief executive officer of NewLake

About Columbia Care Inc.

Columbia Care Inc. is one of the largest fully integrated operators in the global medical cannabis industry with licenses in 15 jurisdictions in the US and the EU. With over 1.4 million sales transactions since its inception, Columbia Care is a patient-centered organization setting the standard for compassion, professionalism, quality, caring and innovation in cannabis, working in collaboration with some of the most renowned and innovative teaching hospitals and medical centers in the world. The Company is committed to providing the type of education and transparency patients deserve and quality of product that clinicians expect. For more information on Columbia Care, please visit www.col-care.com.

About NewLake Capital Partners, Inc.

NewLake is an internally managed, Maryland corporation focused on acquiring specialized industrial and retail properties to be leased to state-licensed cannabis operators. NewLake intends to elect to be taxed as a real estate investment trust for U.S. federal income tax purposes once it meets all applicable criteria.

Original press release

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter